Related Experiment Videos

Carvedilol increases plasma vascular endothelial growth factor (VEGF) in patients with chronic heart failure

R A de Boer¹, H J Siebelink, R A Tio

¹University Hospital Groningen, Thoraxcenter, Department of Cardiology, P.O. Box 30001, 9700 RB, Groningen, Netherlands.

European Journal of Heart Failure

|May 30, 2001

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Differences between men and women in guideline-directed medical therapy implementation, tolerability, and outcomes in heart failure with reduced ejection fraction.

European heart journal. Quality of care & clinical outcomes·2026

Pathophysiological analysis of serially measured plasma biomarkers, remote monitoring and clinical events, in symptomatic patients with moderate to severe chronic heart failure.

International journal of cardiology. Heart & vasculature·2026

Epicardial adipose tissue thickness is associated with circulating biomarkers in individuals without known cardiac disease across a broad adiposity spectrum.

Scientific reports·2026

Low-dose digoxin in patients with heart failure with reduced or mildly reduced ejection fraction: a randomized controlled trial.

Nature medicine·2026

The hemodynamic envelope in cardiogenic shock: A novel paradigm on the safe use of heart failure therapies during temporary mechanical circulatory support.

Trends in cardiovascular medicine·2025

Beyond the gut: Systemic levels of short-chain fatty acids are altered in patients with heart failure.

International journal of cardiology·2025

See all related articles